About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Targeting IDH in AML & FDA Approval of Ivosidenib for IDH+ AML
By
Daniel Pollyea
16 Videos
259 views
June 6, 2018
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
19:10
5th SOHO Italy Annual Conference
SOHO Italy 2023: How I Treat AML at MD Anderson Cancer Center
Feat.
H. Kantarjian
44:26
University of Colorado Division of Hematology
Novel Therapies in AML and MDS
Feat.
D. Pollyea
13:39
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Triplet Regimens in AML: Beyond Azacitidine + Venetoclax
Feat.
C. DiNardo
14:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Immunotherapies in Acute Leukemias: 2024 Update
Feat.
C. Lai
18:48
Current Challenges in Hematology
Venetoclax-Based Combinations in Newly Diagnosed AML: A New Golden S…
Feat.
C. DiNardo
19:51
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
A 50-Year Personal Perspective on the Treatment of AML
Feat.
C. Schiffer
10:31
SOHO Turkey 2023
SOHO Turkey 2023: How I Treat AML
Feat.
F. Ravandi
35:15
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: AML
Feat.
F. Ravandi
11:02
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: AML
Feat.
F. Ravandi
33:22
Yale Cancer Center
Immune Checkpoint Inhibition and Novel Therapies for Myelodysplastic…
Feat.
A. Zeidan
11:17
5th SOHO Italy Annual Conference
SOHO Italy 2023: New and Revised ELN Working Party Guidelines - AML …
Feat.
A. de la Fuente
18:21
SOHO Turkey 2023
SOHO Turkey 2023: MRD Assessment and Management in AML
Feat.
F. Ravandi
14:12
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Future Directions in AML: Optimizing Doublets and Triplets to Improv…
Feat.
N. Daver
14:34
Moffitt Cancer Center
Diagnosis and Management of Differentiation Syndrome in AML
Feat.
J. Lancet
07:10
Current Challenges in Hematology
IDH1-Mutated AML Patient Case
Feat.
A. de la Fuente
21:31
Moffitt Cancer Center
Optimal Use of Targeted Therapy for the Elderly or Unfit AML Patient
Feat.
O. Chan
21:11
Penn Medicine Abramson Cancer Center
Latest Advances in Managing AML in Older Adults - Choosing Therapy a…
Feat.
S. McCurdy
14:08
5th SOHO Italy Annual Conference
SOHO Italy 2023: How I Manage IDH-Mutated AML at MD Anderson Cancer …
Feat.
C. DiNardo
30:14
Tisch Cancer Institute at Mount Sinai
Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: 7…
Feat.
M. Wu
15:38
5th SOHO Italy Annual Conference
SOHO Italy 2023: Is The Future of AML All Oral Therapy?
Feat.
F. Ravandi
